Prescient Therapeutics LimitedASX: PTX

PTX-200 AML Study Expanded

Aug 30, 2018 at 3:30 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment